{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T06:15:08Z","timestamp":1762409708538,"version":"3.44.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cancer"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.currproblcancer.2020.100613","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T08:09:58Z","timestamp":1591949398000},"page":"100613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database"],"prefix":"10.1016","volume":"44","author":[{"given":"Xiang","family":"Bu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linyan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9444-1031","authenticated-orcid":false,"given":"Mingwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.currproblcancer.2020.100613_bib0001","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0002","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.5858\/2009-0583-RAR.1","article-title":"Neuroendocrine tumors of the lung: an update","volume":"134","author":"Rekhtman","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0003","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0004","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jtho.2016.11.2222","article-title":"Neuroendocrine tumors of the lung: current challenges and advances in the diagnosis and management of well-differentiated disease","volume":"12","author":"Hendifar","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.lungcan.2015.08.018","article-title":"Systemic therapy for pulmonary carcinoids","volume":"90","author":"Marquez-Medina","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0006","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.critrevonc.2016.02.009","article-title":"Diagnosis and management of typical and atypical lung carcinoids","volume":"100","author":"Pusceddu","year":"2016","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0007","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.chest.2016.06.018","article-title":"Advances in the diagnosis and management of well-differentiated and intermediate-differentiated neuroendocrine tumors of the lung","volume":"151","author":"Wolin","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10120510","article-title":"Management of typical and atypical pulmonary carcinoids based on different established guidelines","volume":"10","author":"Gosain","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0009","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s12020-013-9911-4","article-title":"Secondary malignancy in patients with sporadic neuroendocrine neoplasia","volume":"44","author":"Krausch","year":"2013","journal-title":"Endocrine"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000381716","article-title":"Incidence of second primary malignancies in patients with neuroendocrine tumours","volume":"102","author":"Clift","year":"2015","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0011","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1530\/ERC-11-0315","article-title":"Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract and pancreas","volume":"19","author":"Kamp","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0012","first-page":"1","article-title":"Statistical methods in cancer research. Volume II\u2013the design and analysis of cohort studies","author":"Breslow","year":"1987","journal-title":"IARC Sci Publ"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0013","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cell.2014.02.031","article-title":"Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing","volume":"156","author":"McFadden","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0014","doi-asserted-by":"crossref","first-page":"e470","DOI":"10.1016\/S1470-2045(18)30455-8","article-title":"Will liquid biopsies improve outcomes for patients with small-cell lung cancer?","volume":"19","author":"Blackhall","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0015","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bjc.6605527","article-title":"Treatment options for small cell lung cancer - do we have more choice?","volume":"102","author":"Puglisi","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0016","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1200\/JCO.1992.10.10.1525","article-title":"Second primary malignancies following diagnosis of small-cell lung cancer","volume":"10","author":"Sagman","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0017","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1158\/1078-0432.CCR-14-2958","article-title":"Small cell lung cancer: will recent progress lead to improved outcomes?","volume":"21","author":"Pietanza","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2019.01.022","article-title":"2017-2018 Scientific advances in thoracic oncology: small cell lung cancer","author":"Zimmerman","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0019","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/annonc\/mds213","article-title":"Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial","volume":"24","author":"Reck","year":"2013","journal-title":"Ann Oncol."},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0020","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1200\/JCO.2010.29.3423","article-title":"Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial","volume":"29","author":"Spigel","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0021","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-018-02011-9","article-title":"The role of immunotherapy in small cell lung cancer","author":"Calles","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0022","doi-asserted-by":"crossref","first-page":"e819","DOI":"10.1200\/JCO.2011.36.2251","article-title":"Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gefitinib","volume":"29","author":"De Pas","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0023","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \"carcinoid\": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.currproblcancer.2020.100613_bib0024","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12890-018-0678-5","article-title":"Incidence and prevalence of neuroendocrine tumors of the lung: analysis of a US commercial insurance claims database","volume":"18","author":"Broder","year":"2018","journal-title":"BMC Pulm Med"}],"container-title":["Current Problems in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147027220301008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147027220301008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T04:08:18Z","timestamp":1758946098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147027220301008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0147027220301008"],"URL":"https:\/\/doi.org\/10.1016\/j.currproblcancer.2020.100613","relation":{},"ISSN":["0147-0272"],"issn-type":[{"type":"print","value":"0147-0272"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.currproblcancer.2020.100613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100613"}}